Bound Company Overview, Contact Details & Competitors

Q: What is Bound's official website and social media links?

Bound's official website is bound.co. Bound has social profiles on LinkedIn.

Q: How many employees does Bound have currently?

Bound has approximately 27 employees.

Q: What technology does Bound use?

Bound's tech stack includes LinkedIn, PWA, LinkedIn Ads, Amazon CloudFront, Kotlin.

Insights

Gathering insights about Bound…

Similar companies to Bound

Bound Tech Stack

Bound uses 8 technology products and services including Microsoft Advertising, Linkedin Insight Tag, LinkedIn Recruiter, and more. Explore Bound's tech stack below.

Microsoft Advertising
Advertising
Linkedin Insight Tag
Analytics
LinkedIn Recruiter
Applicant Tracking Systems
Cybot
Cookie Compliance
LottieFiles
Design
HubSpot
Marketing Automation
Klarna
Payment Processing
reCAPTCHA
Security

Media & News

Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why
Boundless Bio, Inc. (BOLD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Feb 13, 2026 | www.zacks.com
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026.
Feb 05, 2026 | www.globenewswire.com
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
BBI-940 IND accepted; initiation of first-in-human clinical trial on track for the first half of 2026 Portfolio prioritization, including discontinuation of POTENTIATE trial, extends operating runway into the second half of 2028 SAN DIEGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for its novel Kinesin oral degrader program, BBI-940. The Company also provided updates on the POTENTIATE clinical trial of BBI-355 and BBI-825 and its capital position.
Jan 20, 2026 | www.globenewswire.com
BUBBA® UNVEILS A BOLD, NEW BRAND IDENTITY AND NEXT-GEN WATER BOTTLE DESIGNS, TURNING EVERYDAY HYDRATION INTO PERSONAL EXPRESSION
It's Not About the Water, It's About the Drip. bubba®'s New Look, Fashion-forward Finishes, And Bold Colorways, Transform Hydration into a Statement Piece ATLANTA, Jan. 14, 2026 /PRNewswire/ -- Today, bubba® , part of Newell Brands' global portfolio and an emerging leader in oversized, high-performance water bottles, announces a bold evolution of its brand identity alongside the launch of a new generation of reuseable water bottle designs.
Jan 14, 2026 | www.prnewswire.com
21shares launches BOLD ETP combining bitcoin and gold in a single regulated product
Approved by Archax 12/01/2026 Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong.
Jan 13, 2026 | www.globenewswire.com
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Boundless Bio, (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference. The fireside chat session is scheduled for Wednesday, December 3, in New York, NY, at 9:30 a.m.
Nov 24, 2025 | www.globenewswire.com
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
Enrollment ongoing in BBI-355 / BBI-825 combination arm of the POTENTIATE trial Investigational new drug submission for BBI-940 on track, with a first-in-human clinical trial expected to initiate in the first half of 2026 $118 million in cash supports operations into first half of 2028, through expected proof-of-concept clinical readouts for both programs SAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD) , a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced financial results and business highlights for the fiscal quarter ended September 30, 2025. “We are advancing a pipeline rooted in tumor-enabling ecDNA biology to bring forward innovative therapies for patients with oncogene-amplified cancers,” said Zachary Hornby, President and Chief Executive Officer of Boundless Bio.
Nov 05, 2025 | www.globenewswire.com

Bound's Email Address Formats

Bound uses at least 1 format(s):

Bound Email Formats	Example	Percentage
First@bound.co	John@bound.co	43%
Last@bound.co	Doe@bound.co	7%
First@bound.co	John@bound.co	43%
Last@bound.co	Doe@bound.co	7%

Frequently Asked Questions

Where is Bound's headquarters located?

Bound's main headquarters is located at London, England United Kingdom. The company has employees across 2 continents, including EuropeAfrica.

What is Bound's stock symbol?

Bound is a publicly traded company; the company's stock symbol is BOLD.

What is Bound's official website and social media links?

Bound's official website is bound.co and has social profiles on LinkedIn Crunchbase.

What is Bound's NAICS code?

Bound's NAICS code is 5112 - Software Publishers.

How many employees does Bound have currently?

As of February 2026, Bound has approximately 27 employees across 2 continents, including EuropeAfrica. Key team members include Cfo: M. C.Chief Revenue Officer: A. P.Founder And Ceo: S. M. P.. Explore Bound's employee directory with LeadIQ.

What industry does Bound belong to?

Bound operates in the Software Development industry.

What technology does Bound use?

Bound's tech stack includes Microsoft AdvertisingLinkedin Insight TagLinkedIn RecruiterCybotLottieFilesHubSpotKlarnareCAPTCHA.

What is Bound's email format?

Bound's email format typically follows the pattern of First@bound.co. Find more Bound email formats with LeadIQ.

When was Bound founded?

Bound was founded in 2020.

Insights

Similar companies to Bound

Properly

HomeLight

Compass

Redfin

Offerpad

Knock.com

Perch

Sundae | Homebuyers with Heart

Ribbon

Zillow

Orchard

Homie

Opendoor

Bound Tech Stack

Media & News

Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway

BUBBA® UNVEILS A BOLD, NEW BRAND IDENTITY AND NEXT-GEN WATER BOTTLE DESIGNS, TURNING EVERYDAY HYDRATION INTO PERSONAL EXPRESSION

21shares launches BOLD ETP combining bitcoin and gold in a single regulated product

Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights

Bound's Email Address Formats

Frequently Asked Questions

Where is Bound's headquarters located?

What is Bound's stock symbol?

What is Bound's official website and social media links?

What is Bound's NAICS code?

How many employees does Bound have currently?

What industry does Bound belong to?

What technology does Bound use?

What is Bound's email format?

When was Bound founded?

Bound

Company Overview

Media & News

Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?